CASI PHARMACEUTICALS
CASI Pharmaceuticals, Inc. ("CASI", "we" or "us") is a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world. CASI is focused on acquiring, developing and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. CASI is executing its plan to become a biopharmaceutical leader by launching medicines in the greater China market leveraging CASI's China-based regulatory and commercial competencies and its global drug development expertise.
CASI PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Medical Pharmaceutical
Founded:
1991-01-01
Address:
Rockville, Maryland, United States
Country:
United States
Website Url:
http://www.casipharmaceuticals.com
Total Employee:
101+
Status:
Active
Contact:
(240) 864-2643
Email Addresses:
[email protected]
Total Funding:
147.38 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Universal Analytics Nginx Euro
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2006-01-10 | Miikana Therapeutics | Miikana Therapeutics acquired by CASI Pharmaceuticals | 9.96 M USD |
Investors List
Robert W. Duggan
Robert W. Duggan investment in Post-IPO Equity - CASI Pharmaceuticals
ETP Fund
ETP Fund investment in Post-IPO Equity - CASI Pharmaceuticals
IDG Capital
IDG Capital investment in Post-IPO Equity - CASI Pharmaceuticals
IDG Capital
IDG Capital investment in Post-IPO Equity - CASI Pharmaceuticals
Emerging Technology Partners
Emerging Technology Partners investment in Post-IPO Equity - CASI Pharmaceuticals
Accel
Accel investment in Post-IPO Equity - CASI Pharmaceuticals
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - CASI Pharmaceuticals
GE Healthcare
GE Healthcare investment in Post-IPO Debt - CASI Pharmaceuticals
Merrill Lynch
Merrill Lynch investment in Post-IPO Debt - CASI Pharmaceuticals
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-08 | Precision Autoimmune Therapeutics | CASI Pharmaceuticals investment in Venture Round - Precision Autoimmune Therapeutics | 140 M CNY |
| 2019-07-09 | Juventas | CASI Pharmaceuticals investment in Series A - Juventas | 100 M CNY |
Official Site Inspections
http://www.casipharmaceuticals.com Semrush global rank: 1.53 M Semrush visits lastest month: 17.33 K
- Host name: staticip2.multiscreensite.com
- IP address: 100.24.208.97
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
